Article
Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial
4 Mar 2019
Abstract excerpt
STUDY QUESTION: Is oral medroxiprogesterone acetate (MPA) non-inferior compared to ganirelix with respect to the number of mature oocytes (MII) retrieved at ovum pick-up (OPU) in oocyte donation cycles? SUMMARY ANSWER: MPA is comparable to ganirelix in terms of number of MII retrieved at OPU in oocyte donation cycles. WHAT IS KNOWN ALREADY: Oral treatment with MPA inhibits the pituitary LH surge during ovarian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
